MGO One Seven’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

MGO One Seven’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4	Closed	–	–	1924
2017 Q4	$0	Buy	+4	New	+$252	﹤0.01%	1834

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

MGO One Seven's ICPT Position: Q1 2018 in Review

MGO One Seven sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2018, closing a stake of 4 shares.

MGO One Seven first reported a position in ICPT in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 147 funds tracked by Wall St. Rank hold ICPT as of Q1 2018.

MGO One Seven reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
MGO One Seven sold 4 Intercept Pharmaceuticals, Inc. shares in Q1 2018.
MGO One Seven first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
MGO One Seven's Intercept Pharmaceuticals, Inc. position peaked at $0 in Q4 2017.
147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.